Essential Pharmaceuticals releases Cell-Ess media supplement for proteins and vaccines bioproduction Read more
Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration in Patients with Aggressive Form of Brain Cancer Read more